Business

BioPorto A/S raises DKK 33.5 million in new capital round - Change of number of shares and votes

April 25, 2025Announcement no. 12 BioPorto A/S raises DKK 33.5 million in new capital round - Change of number of shares and votes Completion of share capital increase COPENHAGEN, DENMARK, April 25, 2025 (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of Acute Kidney Injury (AKI), decided on April 15, 2025, to complete a private placement of 25,000,000 new shares to exi

articleBioporto A/sApril 25, 20253/company/bioporto-as/news/bioporto-as-raises-dkk-335-million-in-new-capital-round-change-of-number-of-shares-and-votes
BioPorto A/S raises DKK 33.5 million in new capital round - Change of number of shares and votes

About this update from Bioporto A/s

[{"type":"image","alt":"BioPorto A/S","displaySize":"","headline":null,"caption":"BioPorto A/S","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":55,"url":"https://media.zenfs.com/en/globenewswire.com/b7c79bb76fefe5d65277db64dd9691c8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/XFhYiV2fxrmNbtDA3N3v_A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTc3O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/b7c79bb76fefe5d65277db64dd9691c8","width":300,"height":55}},"lazy":false},{"type":"text","content":"April 25, 2025Announcement no. 12","length":34,"tagName":"p"},{"type":"text","content":"                                                                        ","length":432,"tagName":"p"},{"type":"text","content":"BioPorto A/S raises DKK 33.5 million in new capital round - Change of number of shares and votes","length":96,"tagName":"p"},{"type":"text","content":"Completion of share capital increase","length":36,"tagName":"p"},{"type":"text","content":"COPENHAGEN, DENMARK, April 25, 2025 (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of Acute Kidney Injury (AKI), decided on April 15, 2025, to complete a private placement of 25,000,000 new shares to existing larger shareholders, new professional investors, board members and the management team (company announcement no. 11 of April 15, 2025).","length":473,"tagName":"p"},{"type":"text","content":"Completion of the issue","length":23,"tagName":"p"},{"type":"text","content":"BioPorto has now received the full subscription amount and the capital increase of a total nominal amount of DKK 25,000,000 has been registered and completed with the Danish Business Authority.","length":193,"tagName":"p"},{"type":"text","content":"BioPorto’s gross proceeds from the issue will amount to DKK 33,505,000. The new shares correspond to 5.8% of BioPorto’s registered share capital prior to the share capital increase a...

More updates from Bioporto A/s

share capitalThe CompanyDKKDanish Business AuthorityAcute Kidney InjuryBioPortocapital increase